Page last updated: 2024-10-28

haloperidol and Hypomania

haloperidol has been researched along with Hypomania in 6 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research Excerpts

ExcerptRelevanceReference
"Mania (or manic episodes) is a common symptom of bipolar disorder and is frequently accompanied by hyperactivity and delusions; given the cost and resources available, there is a paucity of evidence for direct comparison of different drugs."2.82A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years. ( Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J, 2022)
"As its name suggests, delirious mania presents as a mixture of hyperactive delirium and mania; additional features may include psychosis, autonomic activation, and catatonia."1.62Pseudodelirium: Psychiatric Conditions to Consider on the Differential for Delirium. ( Ainsworth, A; Andrews, P; Ely, EW; Oldham, MA; Roy, K; Wilson, JE, 2021)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's6 (100.00)2.80

Authors

AuthorsStudies
Kishi, T1
Ikuta, T1
Matsuda, Y1
Sakuma, K1
Okuya, M1
Nomura, I1
Hatano, M1
Iwata, N1
Stetson, SR1
Osser, DN1
Hong, Y1
Huang, W1
Cao, D1
Xu, J1
Wei, H1
Zhang, J1
Wang, L1
Khan, N1
Zubair, UB1
Khan, SA1
Islam, JU1
Ali Kazmi, SA1
Khan, A1
Yu, CL1
Carvalho, AF1
Thompson, T1
Tsai, TC1
Tseng, PT1
Hsu, CW1
Hsu, TW1
Liang, CS1
Wilson, JE1
Andrews, P1
Ainsworth, A1
Roy, K1
Ely, EW1
Oldham, MA1

Reviews

4 reviews available for haloperidol and Hypomania

ArticleYear
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Molecular psychiatry, 2022, Volume: 27, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female;

2022
Psychopharmacology of agitation in acute psychotic and manic episodes.
    Current opinion in psychiatry, 2022, 05-01, Volume: 35, Issue:3

    Topics: Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Ma

2022
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
    Psychopharmacology, 2022, Volume: 239, Issue:10

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzo

2022
Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia.
    BMJ mental health, 2023, Volume: 26, Issue:1

    Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Haloperidol; Humans; Mania; Olanzapine; Quetia

2023

Trials

1 trial available for haloperidol and Hypomania

ArticleYear
Comparison of effectiveness between Haloperidol and Quetiapine in acute manic episode.
    JPMA. The Journal of the Pakistan Medical Association, 2022, Volume: 72, Issue:8

    Topics: Antipsychotic Agents; Haloperidol; Humans; Mania; Quetiapine Fumarate; Treatment Outcome

2022

Other Studies

1 other study available for haloperidol and Hypomania

ArticleYear
Pseudodelirium: Psychiatric Conditions to Consider on the Differential for Delirium.
    The Journal of neuropsychiatry and clinical neurosciences, 2021,Fall, Volume: 33, Issue:4

    Topics: Antipsychotic Agents; Brief Psychiatric Rating Scale; Catatonia; Delirium; Diagnosis, Differential;

2021